# Paromomycin or Metronidazole for Symptomatic Dientamoeba Fragilis in Adults

> **NCT06907498** · NA · RECRUITING · sponsor: **Sheba Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Dientamoeba Fragilis Infection

## Interventions

- **DRUG:** Paromomycin

## Key facts

- **NCT ID:** NCT06907498
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-22
- **Primary completion:** 2026-06
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06907498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06907498, "Paromomycin or Metronidazole for Symptomatic Dientamoeba Fragilis in Adults". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06907498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*